Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease

Biochemical and Biophysical Research Communications

Volumn 353, Issue 1, 2007, Pages 104-108

  Mehrad, Borna ^a   Burdick, Marie D ^a   Zisman, David A ^b   Keane, Michael P ^b   Belperio, John A ^b   Strieter, Robert M ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; Cryptogenic fibrosing alveolitis; Fibroblast; Fibroblastic foci; Idiopathic interstitial pneumonia; Idiopathic pulmonary fibrosis; Myofibroblast; Non specific interstitial pneumonia; Stem cells; Usual interstitial pneumonia

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROCYTE; FIBROSING ALVEOLITIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

BLOOD CELLS; CELLS, CULTURED; CHEMOKINES, CXC; HUMANS; PULMONARY FIBROSIS; RECEPTORS, CXCR4;

ANIMALIA;

EID: 33845639241     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.149     Document Type: Article

References (26)

1. Anonymous, American Thoracic Society, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement, American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am. J. Respir. Crit. Care Med. 161 (2000) 646-664.
2. S. American Thoracic, and S. European Respiratory, American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, Am. J. Respir. Crit. Care Med. 165 (2002) 277-304.
3. Nagai S., Handa T., Tabuena R., Kitaichi M., and Izumi T. Nonspecific interstitial pneumonia: a real clinical entity?. Clin. Chest. Med. 25 (2004) 705-715 vi
4. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157 (1998) 1301-1315
5. Travis W.D., Matsui K., Moss J., and Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 24 (2000) 19-33
6. Kuhn C., and McDonald J.A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138 (1991) 1257-1265
7. Nicholson A.G., Fulford L.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166 (2002) 173-177
8. King Jr. T.E., Schwarz M.I., Brown K., Tooze J.A., Colby T.V., Waldron Jr. J.A., Flint A., Thurlbeck W., and Cherniack R.M. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 164 (2001) 1025-1032
9. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., Sheppard D., and Chapman H.A. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA 103 (2006) 13180-13185
10. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., and Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114 (2004) 438-446
11. Metz C.N. Fibrocytes: a unique cell population implicated in wound healing. Cell. Mol. Life Sci. 60 (2003) 1342-1350
12. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., and Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell. Biol. 36 (2004) 598-606
13. Hong K.M., Burdick M.D., Phillips R.J., Heber D., and Strieter R.M. Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J. 19 (2005) 2029-2031
14. Keane M.P., Belperio J.A., Arenberg D.A., Burdick M.D., Xu Z.J., Xue Y.Y., and Strieter R.M. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J. Immunol. 163 (1999) 5686-5692
15. Ham J.M., Kunkel S.L., Dibb C.R., Standiford T.J., Rolfe M.W., and Strieter R.M. Chemotactic cytokine (IL-8 and MCP-1) gene expression by human whole blood. Immunol. Invest. 20 (1991) 387-394
16. Strieter R.M., Remick D.G., Ham J.M., Colletti L.M., Lynch III J.P., and Kunkel S.L. Tumor necrosis factor-alpha gene expression in human whole blood. J. Leukoc. Biol. 47 (1990) 366-370
17. Arenberg D.A., Kunkel S.L., Polverini P.J., Glass M., Burdick M.D., and Strieter R.M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97 (1996) 2792-2802
18. Strieter R.M., Starko K.M., Enelow R.I., Noth I., and Valentine V.G. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 170 (2004) 133-140
19. Phan S.H. The myofibroblast in pulmonary fibrosis. Chest 122 (2002) 286S-289S
20. Xing Z., Tremblay G.M., Sime P.J., and Gauldie J. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation. Am. J. Pathol. 150 (1997) 59-66
21. Abe R., Donnelly S.C., Peng T., Bucala R., and Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166 (2001) 7556-7562
22. Schmidt M., Sun G., Stacey M.A., Mori L., and Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171 (2003) 380-389
23. Chesney J., Bacher M., Bender A., and Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl. Acad. Sci. USA 94 (1997) 6307-6312
24. Noble P.W. Idiopathic pulmonary fibrosis: natural history and prognosis. Clin. Chest Med. 27 (2006) S11-S16 v
25. Gharaee-Kermani M., Ullenbruch M., and Phan S.H. Animal models of pulmonary fibrosis. Methods Mol. Med. 117 (2005) 251-259
26. Hartlapp I., Abe R., Saeed R.W., Peng T., Voelter W., Bucala R., and Metz C.N. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 15 (2001) 2215-2224